Abstract:Objective This study aims to assess the feasibility of detecting and diagnosing Duchenne muscular dystrophy (DMD) during prenatal screening for chromosome abnormalities using cell-free fetal DNA extracted from peripheral blood samples of pregnant women. Study Design Two pregnant women identified as high risk through noninvasive prenatal testing (NIPT) underwent amniocentesis to obtain fetal cells. Subsequent fetal chromosomal karyotyping was conducted, and genomic DNA from fetal cells was extracted for copy number variation sequencing (CNV-Seq) analysis, complemented by multiplex ligation-dependent probe amplification (MLPA) to detect deletions or duplications within the DMD gene. Results NIPT results for the two samples indicated potential abnormalities involving chromosomes 21 and 18. However, karyotype analysis of the fetuses revealed no abnormalities. CNV-Seq identified deletions of 0.28 and 0.18 Mb within chromosome Xp21.1, encompassing the DMD gene, in each fetus. In family 1, MLPA results indicated a maternal heterozygous deletion spanning exons 12 to 41 in the DMD gene, while the fetus exhibited deletions in exons 12 to 41. In family 2, MLPA results confirmed normal DMD gene status in the pregnant woman's peripheral blood genomic DNA but revealed a fetal deletion spanning exons 48 to 52. Both fetuses were diagnosed with DMD and subsequently underwent termination. Conclusion Abnormalities identified through NIPT necessitate further invasive prenatal diagnostic procedures. For cases involving chromosomal microdeletions or microduplications, a combination of karyotyping and CNV-Seq testing is essential for comprehensive diagnosis. NIPT followed by CNV-Seq may offer insights into large exon deletions within the DMD gene in specific instances. Key Points NIPT results can offer valuable insights into the deletion and duplication of DMD gene for the fetus. It's crucial to notice unexpected findings in NIPT. A combination of karyotyping and CNV-Seq testing is essential for comprehensive diagnosis. Conceptualization: X.K., G.Z.; investigation: G.Z., L.L., P.S.; data curation: G.Z., M.G., S.Y.; experiment curation: G.Z.; writing—original draft: G.Z.; writing—review and editing: X.K.; funding acquisition: G.Z. All authors contributed to the article and approved the submitted version. Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. Received: 23 September 2024 Accepted: 30 October 2024 Accepted Manuscript online: 04 November 2024 Article published online: 25 November 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Incidental Discovery of DMD Gene Deletions by Chromosomal Microarray Analysis

Genetic Identification of Pathogenic Variations of the DMD Gene: a Retrospective Study from 10,481 Neonatal Patients Based on Next-Generation Sequencing Data

Chromosomal Microarray Analysis in Fetuses with Congenital Anomalies of the Kidney and Urinary Tract: A Prospective Cohort Study and Meta‐analysis

[Evaluation of Detection and Analysis of Chromosome 22q11.2 Microdeletion by Multiple Ligation-Dependent Probe Amplification Assay].

Unexpected DMD Gene Mutations Detected by CMA and CNV-seq in Amniotic Fluid and Aborted Fetus Samples

Unexpected Findings of Duchenne Muscular Dystrophy in Prenatal Screening of Chromosome Abnormality Based on Cell-Free Fetal DNA

Study on Duchenne muscular dystrophy gene mutation and prenatal diagnosis]

Comprehensive Genetic Diagnosis of Patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) and Pathogenicity Analysis of Splice Site Variants in the DMD Gene

[Combining approach with multiplex PCR and MLPA to detect deletion and duplication in DMD patients, carriers, and prenatal diagnosis].

[The Diagnostic Value of Chromosome Microarray Analysis Technique in the Genetic Causes of Children with Intellectual Disability or Global Developmental Delay].

[Mutation Analysis and Prenatal Diagnosis for 50 Pedigrees Affected with Duchenne/Becker Muscular Dystrophy].

Chromosomal microarray analysis for prenatal diagnosis of uniparental disomy: a retrospective study

Case Report: Identification of Maternal Low-Level Mosaicism in the Dystrophin Gene by Droplet Digital Polymerase Chain Reaction

Clinical Analysis Of 194 Cases Of Amniotic Fluid Chromosome Microarray Detection

Prenatal Diagnosis Using Chromosomal Microarray Analysis in High-Risk Pregnancies

Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy

Prenatal Gene Diagnosis for the Duchenne Muscular Dystrophy Risk Fetus by Molecule Markers

Detection of chromosome 5q interstitial deletion of 5q14.3-q31.1 by chromosome microarray analysis in a second-trimester fetus with multiple congenital anomalies and a literature review of chromosome 5q interstitial deletion syndrome

Screening of Duchenne Muscular Dystrophy (DMD) Mutations and Investigating Its Mutational Mechanism in Chinese Patients.

Clinical Application of Prenatal Gene Diagnosis of Duchenne and Becker Muscular Dystrophy

Development of a Comprehensive Real-Time PCR Assay for Dystrophin Gene Analysis and Prenatal Diagnosis of Chinese Families.